2-[4-[(2-fluorophenyl)methyl]piperazin-1-yl]-6-(propanoylamino)quinoline-4-carboxylic acid;trihydrochloride
C24H28Cl3FN4O3 — CID 146058241
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[(2-fluorophenyl)methyl]piperazin-1-yl]-6-(propanoylamino)quinoline-4-carboxylic acid;trihydrochloride
2-[4-[(2-fluorophenyl)methyl]piperazin-1-yl]-6-(propanoylamino)quinoline-4-carboxylic acid;trihydrochloride (PubChem CID 146058241) has the molecular formula C24H28Cl3FN4O3 and a molecular weight of 545.87 g/mol. Its IUPAC name is 2-[4-[(2-fluorophenyl)methyl]piperazin-1-yl]-6-(propanoylamino)quinoline-4-carboxylic acid;trihydrochloride.
Molecular Properties
| Compound Name | 2-[4-[(2-fluorophenyl)methyl]piperazin-1-yl]-6-(propanoylamino)quinoline-4-carboxylic acid;trihydrochloride |
|---|---|
| PubChem CID | 146058241 |
| Molecular Formula | C24H28Cl3FN4O3 |
| Molecular Weight | 545.87 g/mol |
| Exact Mass | 544.12 |
| IUPAC Name | 2-[4-[(2-fluorophenyl)methyl]piperazin-1-yl]-6-(propanoylamino)quinoline-4-carboxylic acid;trihydrochloride |
| SMILES | CCC(=O)Nc1ccc2nc(N3CCN(Cc4ccccc4F)CC3)cc(C(=O)O)c2c1.Cl.Cl.Cl |
| InChI | InChI=1S/C24H25FN4O3.3ClH/c1-2-23(30)26-17-7-8-21-18(13-17)19(24(31)32)14-22(27-21)29-11-9-28(10-12-29)15-16-5-3-4-6-20(16)25;;;/h3-8,13-14H,2,9-12,15H2,1H3,(H,26,30)(H,31,32);3*1H |
| InChIKey | UQUZRKRPZWITIH-UHFFFAOYSA-N |
| XLogP | 5.01 |
| TPSA | 85.77 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 545.87 |
| LogP ≤ 5 | 5.01 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146058241 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.